Systematic review shows low-dose caffeine capsules improve time-trial performance in endurance athletes, highlighting effective methods.
Background/Objectives: Caffeine is a well-established ergogenic aid for endurance performance. However, the optimal intake strategy, specifically the administration method and dosage, remains uncertain. This systematic review and network meta-analysis compared the effectiveness of different caffeine administration methods and dosages on time-trial performance. Methods: A systematic review and network meta-analysis were conducted following PRISMA guidelines. A systematic search of PubMed, Embase, Web of Science, Scopus, and SPORTDiscus was conducted up to July 2025. Eligible studies were independently screened and quality-assessed by two reviewers. Pairwise and network meta-analyses were conducted to examine the effects of caffeine administration methods (e.g., capsules/tablets, gum, mouth rinse) and dosages (low: ≤3 mg/kg; moderate: 4–6 mg/kg) on time-trial performance. Results: Forty-eight studies with 612 participants were included. Low-dose capsules most effectively reduced completion time (standardized mean differences [SMD] = −0.34; 95% confidence interval [CI] −0.62, −0.06), followed by moderate-dose capsules (SMD = −0.31; 95% CI: −0.45, −0.17) and moderate-dose gum (SMD = −0.30; 95% CI: −0.57, −0.02). Low-dose capsules also had the highest probability of improving mean power output (SMD = 0.38; 95% CI: 0.09, 0.67), with moderate-dose capsules ranking second (SMD = 0.30; 95% CI: 0.12, 0.48). Conclusions: This systematic review and network meta-analysis identified low-dose caffeine capsules (≈3 mg/kg) as the most effective strategy for improving time-trial performance, with moderate-dose capsules and gum serving as viable alternatives. While these findings provide robust, actionable evidence for practitioners, meaningful inter-individual variability persists. Accordingly, future studies should integrate deeper mechanistic profiling (e.g., genetics and body composition) to advance personalized, evidence-based caffeine supplementation for athletes.
No takes yet. Share an insight, caveat, or question.
Li Ding (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: